Dealing with colorectal cancer in New Zealand
Church, J.M.
New Zealand Medical Journal 126(1382): 7-10
2013
ISSN/ISBN: 1175-8716 PMID: 24154765 Document Number: 664401
Document emailed within 1 workday
Related Documents
James, P.; Parry, S.; Arnold, J.; Winship, I. 2006: Confirming a diagnosis of hereditary colorectal cancer: the impact of a Familial Bowel Cancer Registry in New Zealand New Zealand Medical Journal 119(1242): U2168Keating, J.; Pater, P.; Lolohea, S.; Wickremesekera, K. 2003: The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry? New Zealand Medical Journal 116(1174): U437
Jass, J.R.; Stewart, S.W.; Chapman, C.J.; Lane, M.R. 1993: Establishment of a registry for hereditary nonpolyposis colorectal cancer in New Zealand New Zealand Medical Journal 106(960): 309-311
Robinson, B.; Frizelle, F.; Dickson, M.; Frampton, C. 2005: Colorectal cancer treated at Christchurch Hospital, new Zealand: a comparison of 1993 and 1998 cohorts New Zealand Medical Journal 118(1210): U1323
Aaltonen, L.A.; Sankila, R.; Mecklin, J.P.; Järvinen, H.; Pukkala, E.; Peltomäki, P.; de la Chapelle, A. 1994: A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden Cancer Detection and Prevention 18(1): 57-63
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Ishida, H.; Fujioka, M.; Ohsawa, T.; Takeuchi, I.; Nakada, H.; Ishizuka, N.; Yokoyama, M.; Inokuma, S.; Yamada, H.; Odaka, A.; Hoshino, T.; Murata, N.; Hashimoto, D.; Matsumoto, Y.; Miura, T. 2001: Effect of peroral doxifluridine plus hepatic arterial infusion for synchronous liver metastasis of colorectal cancer--correlation with the expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in primary colorectal cancer lesions Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(11): 1624-1627
Connolly, A.B.; Frizelle, F.A.; Keating, J.P.; Lynch, A.C.; Thompson-Fawcett, M.W.; Robertson, G.M. 2002: Review of developments in colorectal surgery in New Zealand New Zealand Medical Journal 115(1155): 262-265
1987: Dealing with drugs Dealing with drugs by Dixon A Published by BBC Publications 208pp £7.95 0-563-21135-0 [Formula: see text Nursing Standard 1987) 2(5): 34-35
Beuran, M.; Chiotoroiu, A.L.; Chilie, A.; Morteanu, S.; Vartic, M.; Avram, M.; Roşu, O.; Lică, I. 2010: Stapled vs. hand-sewn colorectal anastomosis in complicated colorectal cancer--a retrospective study Chirurgia 105(5): 645-651
Bershteĭn, L.M.; Barchuk, A.S.; Gershfel'd, E.D.; Kovalevskiĭ, A.I.; Maksimov, S.I.; Danilova, M.A.; Barash, I.A.; Meshkova, I.E.; Moiseenko, V.M.; Novik, A.V.; Pozharisskiĭ, K.M.; Semiglazov, V.F.; Tsyrlina, E.V.; Chernobrovkina, A.E. 2007: Use of aromatase and its inhibitors in dealing with different oncological pathologies other than breast cancer Voprosy Onkologii 53(1): 7-13
Vagliasindi, A.; Sivelli, R.; Gualtierotti, M.; Piccolo, D.; Bertagni, A.; Sianesi, M. 2003: Are small-size depressed-type colorectal neoplasias really the expression of a early stage of colorectal cancer. Apropos of a clinical case Tumori 89(4 Suppl): 155-158
Kanczuga-Koda, L.; Koda, M.; Sulkowski, S.; Wincewicz, A.; Zalewski, B.; Sulkowska, M. 2010: Gradual loss of functional gap junction within progression of colorectal cancer -- a shift from membranous CX32 and CX43 expression to cytoplasmic pattern during colorectal carcinogenesis In Vivo 24(1): 101-107
Zou, Y.-f.; Cai, Z.-r.; Chen, Y.-f.; Rong, Y.-m.; Wu, X.-r.; Yuan, R.-x.; He, X.-s.; Wu, X.-j.; Lan, P. 2013: Comparison of local immune microenvironment between liver-metastasis colorectal cancer and non-liver-metastasis colorectal cancer Zhonghua Wei Chang Wai Ke Za Zhi 16(6): 547-551
Gifford, E. 1976: Report on five and a half years of the Cancer Detection Centre, Aukland Division, Cancer Society of New Zealand New Zealand Medical Journal 84(571): 195-197
Kozuszko, B.; Skrzydlewski, Z.; Sulkowska, M.; Snarska, J.; Kozłowski, M.; Skrzydlewska, E.; Zalewski, B. 2001: Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 11(63): 218-220
Gil-Ad, I.; Zolokov, A.; Lomnitski, L.; Taler, M.; Bar, M.; Luria, D.; Ram, E.; Weizman, A. 2008: Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice International Journal of Oncology 33(2): 277-286
McCoy, K.L.; Kendrick, L.; Chused, T.M. 1986: Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice Journal of Immunology 136(4): 1217-1222
Takahashi, K.; Hiramatsu, K.; Kawakita, M.; Mori, T.; Yamaguchi, T.; Matsumoto, H.; Miyamoto, H.; Tamamori, Y. 2004: The significance of urine di-acetyl spermine level as a cancer marker for colorectal cancer Rinsho Byori. Japanese Journal of Clinical Pathology 52(4): 332-335
Khalil, S.; Ceccarelli, F. 2009: Colorectal cancer after breast cancer: magnitude of risk in clinical practice and in the literature Tumori 95(1): 28-31